Basic Information
| LncRNA/CircRNA Name | DLX6-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:96955141-97014065 |
| Ensemble | ENSG00000231764 |
| Refseq | NR_015448 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | RT-qPCR, Western blot |
| Sample | cervical cancer tissue |
| Expression Pattern | up-regulated |
| Function Description | DLX6-AS1 accelerates the progression of CC through sponging miR-16-5p and upregulates ARPP19 |
| Pubmed ID | 32077747 |
| Year | 2020 |
| Title | Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis |
External Links
| Links for DLX6-AS1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |